Back
ESC2025 Premium Access

Mid-term benefit of pharmacological chaperone therapy on cardiac manifestation in Japanese Fabry disease

Session: New perspectives in cardiology (1) - Hypertrophic cardiomyopathy and phenocopies
Topic: Infiltrative Myocardial Disease
Speaker: Assistant Professor A. Nojiri (Tokyo, JP)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Assistant Professor Ayumi Nojiri

The Jikei University School of Medicine, Tokyo (Japan)
0 follower

10 more presentations in this session

Discussant - Hypertrophic cardiomyopathy and phenocopies

Access
Like
Thumbnail

Novel screening for Fabry disease in patients with cardiovascular phenotype: a multi-centre, prospective study

Speaker: Professor J. Choi (Seoul, KR)

Access
Abstract
Like
Thumbnail

Impact of cardiac magnetic resonance on the clinical management of patients with Fabry disease: data from the CMR italian research and clinical network for Fabry disease (CIRCLE-FD)

Speaker: Doctor G. De Angeli (San Donato Milanese, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Meta-analysis of 20 years of research on mortality and sudden cardiac death in Fabry disease: more fear than fatalities?

Speaker: Doctor I. Mattig (Berlin, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Association between myocardial strain and cardiopulmonary exercise testing in patients with hypertrophic cardiomyopathy

Speaker: Miss F. Cantora (Buenos Aires, AR)

Access
Abstract
Like
Thumbnail

Access the full session

New perspectives in cardiology (1) - Hypertrophic cardiomyopathy and phenocopies

Speakers: Assistant Professor A. Nojiri, Professor J. Choi, Doctor G. De Angeli, Doctor I. Mattig, Miss F. Cantora
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources